The European Commission is trialling using European open source software to run its internal communications, a spokesperson confirmed to Euractiv. The move comes at a time of growing concern within ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Pfizer, NYSE:PFE, has entered a global licensing agreement ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

The Matrix View in Cakewalk is a powerful tool for organizing and triggering musical ideas in a non-linear fashion, ideal for live performances, composing, or experimenting with loops and clips. This ...

Plus: Elon Musk tried to persuade Mark Zuckerberg to invest in OpenAI This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Ambitious targets drive progress—but how do we know if a target is truly ambitious? This video explores how the FAB Matrix evaluates ambitiousness by comparing proposed targets to business-as-usual ...